Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,386 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Active, Not Recruiting

REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania

NCT06170671

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Piteşti, Argeş, Romania
  • Research Site Oradea, Bihor County, Romania
  • Research Site Cluj-Napoca, Cluj, Romania
  • Research Site Craiova, Dolj, Romania
View all 19 locations
View Trial Details
Active, Not Recruiting

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

NCT01787409

Conditions
Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +40 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

NCT04282811

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Aou Arcispedale Sant'Anna - Cona (Fe) - Uoc Ematologia E Fisiopatologia Della Coagulazione Cona, Ferrara, Italy
  • Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia Alessandria, Italy
  • Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto Bari, Italy
  • Ao Brotzu, Presidio Ospedaliero A. Businco - Cagliari - Sc Ematologia E Ctmo Cagliari, Italy
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL

NCT04722172

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
  • Hackensack Meridian Health (Data collection only) Hackensack, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL

NCT03960840

Conditions
Acute Lymphoblastic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +23 more
Locations
  • University of California LA Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Uni of Chi Medi Ctr Hema and Onco Chicago, Illinois, United States
View all 37 locations
View Trial Details

Related conditions